Profile of brivaracetam and its potential in the treatment of epilepsy

Brivaracetam (BRV) (UCB 34714) is currently under review by the US Food and Drug Administration and European Medicines Agency for approval as an add-on treatment for adult patients with partial seizures. Similar to levetiracetam (LEV), BRV acts as a high-affinity ligand of the synaptic vesicle prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferlazzo, Edoardo, Russo, Emilio, Mumoli, Laura, Sueri, Chiara, Gasparini, Sara, Palleria, Caterina, Labate, Angelo, Gambardella, Antonio, De Sarro, Giovambattista, Aguglia, Umberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670022/
https://www.ncbi.nlm.nih.gov/pubmed/26664121
http://dx.doi.org/10.2147/NDT.S60849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670022/
https://www.ncbi.nlm.nih.gov/pubmed/26664121
http://dx.doi.org/10.2147/NDT.S60849

Ejemplares similares